Trade Summary

2 days ago, Lillie James Woodruff, serving as Chief Scientific Officer at MapLight Therapeutics, Inc. (MPLT), sold 22,082 shares at $12.54 per share, for a total transaction value of $276,908.28. Following this transaction, Lillie James Woodruff now holds 202,380 shares of MPLT.

This sale represents a 9.84% decrease in Lillie James Woodruff's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 3, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, August 5, 2026 (accepted Aug 4, 8:39 PM ET), 2 days after the trade was made.

MapLight Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.